Home » Bio
Targeting TMPRSS2-ERG in Prostate Cancer Approximately half..
David Y. Takeda, MD, PhD:
Dana Farber Cancer Institute
Mentors:
Todd Golub, MD, Levi Garraway, MD, PhD, William Hahn, MD, PhD
Evaluation of Bindarit, a Novel Inhibitor of..
Designation:
Professor, Pharmacology & Molecular Sciences
University:
The Johns Hopkins University School of Medicine
Dr. Redmond earned a BS in Biology..
William L. Redmond, PhD:
Providence Portland Medical Center – Portland, OR
Determining the link between dietary carcinogens, pathogenic..
Karen Sfanos, PhD:
Johns Hopkins University School of Medicine
Mentors:
Angelo deMarzo, MD, PhD and William Nelson, MD, PhD
Targeting MYC-dependent metabolism in prostate cancer The..
Martin Lukas Sos, MD:
University of California, San Francisco
Mentors:
Kevan Shokat, PhD; Phillip Febbo, MD; Davide Ruggero, PhD
Androgen receptor splice variants: novel drivers of..
Luke Selth, PhD:
University of Adelaide, Dame Roma Mitchell Cancer Research Laboratories
Mentor:
Wayne Tilley, PhD
The role of recurrent gene fusion SDK1-AMACR..
Shancheng Ren, MD, PhD:
Shanghai Changhai Hospital
Mentor:
Yinghao Sun, MD, PhD
Identification and integration of clinical features, genetic..
Paul Nguyen, MD:
Dana-Farber Cancer Institute, Harvard University
Mentors:
Anthony D’Amico, MD, PhD and Phillip Kantoff, MD
Evaluating the contribution of AR deficient stem/progenitor..
David Mulholland, PhD:
Icahn School of Medicine at Mount Sinai
Mentor:
Hong Wu, MD, PhD
Dr. Pomerantz earned a BS degree in..
Award1:
The 2008 William L. Edwards – PCF Young Investigator Award (first and second year)
Award2:
The 2008 David Epstein – PCF Young Investigator Award (third year)
Mark Pomerantz, MD:
Dana-Farber Cancer Institute – Boston, MA
Determining the role of the androgen receptor..
Heather Montie, PhD:
Philadelphia College of Osteopathic Medicine
Mentors:
Diane Merry, PhD and Karen Knudsen, PhD
GPR30 as a potential therapeutic target for..
Hung-Ming Lam, PhD:
University of Washington
Mentor:
Shuk-Mei Ho, PhD
Lifestyle, guidelines, and etools to improve prostate..
Stacey Kenfield, ScD:
University of California, San Francisco
Mentor:
June Chan, ScD
Investigating the biological significance of novel recurrent..
Kalpana Kannan, PhD:
Baylor College of Medicine
Mentor:
Laising Yen, PhD and Michael Ittman, MD, PhD
Dr. Memarzadeh earned her BS in Neuroscience..
Sanaz Memarzadeh, MD, PhD:
University of California, Los Angeles – Los Angeles, CA
Investigation of genomic mechanisms of androgen biosynthesis..
Terence Friedlander, MD:
University of California, San Francisco
Mentor:
Charles Ryan, MD and Pamela Paris, PhD
Dr. Jain earned her BS in Zoology..
Anjali Jain, PhD:
Cedars-Sinai Medical Center – Los Angeles, CA
Identifying non-coding RNA repertoires of aggressive prostate..
Stephen Finn, MBBS, PhD:
University of Dublin, Trinity College
Mentors:
John O’Leary, MD, PhD and Lorelei Mucci, ScD, MPH
Dr. Holt earned a BA in Biology..
Sarah Holt, PhD:
Fred Hutchinson Cancer Research Center – Seattle, WA
Systematic identification of genetic variants within AR..
Junjie Feng, PhD:
Wake Forest University
Mentor:
Jiangfeng Xu, MD, PhD
Dr. Harzstark earned a BS degree in..
Andrea Harzstark, MD:
University of California, San Francisco – San Francisco, CA
Nanotargeting Estrogen Receptor regulated Long Non Coding..
Dimple Chakravarty, PhD, DVM:
Weill Cornell Medical College
Mentor:
Mark Rubin, MD
Dr. Harui earned a BS in Pharmaceutical..
Airi Harui, PhD:
University of California, Los Angeles – Los Angeles, CA
Dr. Guzzo earned a BS in Biology..
Thomas Guzzo, MD:
University of Pennsylvania – Philadelphia, PA
Prostate cancer diagnosis and precision medicine treatment..
Jeremy Durack, MD, MS:
Memorial Sloan-Kettering Cancer Center
Mentor:
Howard Scher, MD
Proposal Title:
Rapid Spectroscopic Assessment of Targeted Prostate Cancer Biopsy Sufficiency at the Point-of-Care
Growing clinical evidence suggests that a majority..
Shalini S. Yadav, PhD:
Mount Sinai School of Medicine
Mentors:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
Dr. Frank earned his certification in Nuclear..
Steven Frank, MD:
The University of Texas MD Anderson Cancer Center – Houston, TX
Treatment of advanced, metastatic prostate cancer, although..
Daniel Thorek, PhD:
Johns Hopkins University
Mentors:
David Scheinberg, MD, PhD and Steve Larson, MD
Project Title:
Alpha-particle therapy by 225Actinium-labeled prostate kallikrein-specific antibody to eradicate advanced disease
Dr. Feldman earned a BA degree in..
Adam Feldman, MD:
Massachusetts General Hospital Cancer Center – Boston, MA
IGF (Insulin-like Growth Factor) receptor is dysregulated..
Nicole Simone, MD:
Thomas Jefferson University
Mentors:
Adam Dicker, MD, PhD, Karen Knudsen, PhD and Peter Carroll, MD
Project Title:
Metabolic approaches for targeting multiple components of the IGF-1R pathway in prostate cancer
Deficiencies in the repair of DNA are..
Matthew Schiewer, PhD:
Thomas Jefferson University
Mentor:
Karen Knudsen, PhD
Project Title:
Determining the translation capacity of the PARP-1/AR axis in prostate cancer
Dr. Efsathiou earned both MD and PhD..
Eleni Efstathiou, MD, PhD:
The University of Texas MD Anderson Cancer Center – Houston, TX
Low vitamin D levels in blood have..
Jennifer Rider, ScD:
Harvard School of Public Health
Mentors:
Lorelei Mucci, ScD and Myles Brown, MD
Project Title:
The immunomodulatory and androgen-associated actions of vitamin D in prostate cancer
Colin Pritchard, MD, PhD:
University of Washington
Mentors:
Peter Nelson, MD
Project Title:
Targeting the ‘Hypermutated Subtype’ of Prostate Cancer: From Mechanism to Implementation of Genomic Testing for Precision Therapy”
Dr. Dehm completed a BS and PhD..
Scott M. Dehm, PhD:
Masonic Cancer Center, University of Minnesota – Minneapolis, MN
Dr. Choudhury earned a BA in Chemistry..
Atish Dipankar Choudhury, MD, PhD:
Dana-Farber Cancer Institute – Boston, MA